HSBC 2015 Annual Report Download - page 255

HSBC HOLDINGS PLC
253
Strategic Report Financial Review Corporate Governance Financial Statements Shareholder Information
Marc Moses, 58
Group Chief Risk Officer
Appointed to the Board: January 2014
Skills and experience: Marc joined HSBC in 2005 as Chief
Financial and Risk Officer, Global Banking and Markets and
in December 2010 became Group Chief Risk Officer. He has
extensive risk management and financial experience. Marc
is a Fellow of the Institute of Chartered Accountants in
England and Wales. He was a European chief financial
officer at JP Morgan and an audit partner at
PricewaterhouseCoopers.
Sir Simon Robertson, 74
Deputy Chairman
Appointed to the Board: January 2006.
Deputy Chairman since December
2010. He will retire from the Board at
the conclusion of the HSBC Holdings
AGM on 22 April 2016.
Member of the Group Remuneration Committee.
Skills and experience: Simon has a background in
international corporate advisory work with a wealth of
experience in mergers and acquisitions, merchant banking,
investment banking and financial markets. Other former
appointments include serving as non-executive chair
of Rolls-Royce Holdings plc, non-executive director of the
Royal Opera House Covent Garden Limited and NewShore
Partners Limited and trustee of the Eden Project Trust.
Current appointments include: Simon is the founding
member of Simon Robertson Associates LLP. He is a
non-executive director of Berry Bros. & Rudd Limited,
The Economist Newspaper Limited, Troy Asset
Management and is a director of Immodulon Therapeutics
Limited.
Jonathan Symonds, CBE, 56
Independent non-executive Director
Appointed to the Board: April 2014
Chairman of the Group Audit Committee and a member of the
Conduct & Values Committee.
Skills and experience: Jonathan has extensive international
financial experience, having worked in the UK, US and
Switzerland. He served as Chief Financial Officer of Novartis
AG and AstraZeneca plc. Jonathan is a Fellow of the Institute
of Chartered Accountants in England and Wales. Other
former appointments include serving as partner and
Managing Director of Goldman Sachs, and a partner of
KPMG. He was a non-executive director and chair of the
Audit Committee of Diageo plc.
Current appointments include: Jonathan is Chairman of
HSBC Bank plc, Innocoll AG and Proteus Digital Health Inc.
and is a non-executive director of Genomics England Limited.
Pauline van der Meer
Mohr, 56
Independent non-executive Director
Appointed to the Board: September
2015
With effect from 1 January 2016: Member of the Group
Remuneration Committee and the Conduct & Values Committee.
Skills and experience: Pauline has extensive legal and
human resources experience across a number of different
sectors, and contributed to the Dutch Banking Code
Monitoring Commission. Other former appointments
include serving as President of Erasmus University
Rotterdam, Senior Executive Vice President and Head of
Group Human Resources at ABN AMRO Bank NV, Group
Human Resources Director at TNT NV, HR Director,
Information Technology, Royal Dutch Shell Group and
Senior Legal Counsel, Shell International.
Current appointments include: Pauline is Chairman of the
supervisory board of EY Netherlands. She is also a member
of the supervisory boards of ASML Holding NV and Royal
DSM NV.
Paul Walsh, 60
Independent non-executive Director
Appointed to the Board: 1 January
2016
Member of the Group Remuneration Committee.
Skills and experience: Paul has extensive international
business experience gained as Group Chief Executive of
Diageo plc for 12 years, having originally joined the Board
of its predecessor, Grand Metropolitan plc, in 1995. He was
also a non-executive director of Unilever PLC, United Spirits
Limited and Centrica plc. Paul is a Fellow of the Chartered
Institute of Management Accountants.
Current appointments include: Paul is Chairman of
Compass Group PLC, Avanti Communications Group Plc
and Chime Communications Limited and a non-executive
director of FedEx Corporation, RM2 International S.A.
and Simpsons Malt Limited.